Further randomized controlled trials of tissue plasminogen activator within 3 hours are required.
Lindley
R I
RI
Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK.
D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010820:Physicians; D011364:Professional Practice; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator